1. Chen, Zhao-Hui, Tian, Yao, Zhou, Guang-Lei, Cao, Xu-Chen, Yu, Yue. 2023. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling. In Breast cancer research : BCR, 25, 22. doi:10.1186/s13058-023-01620-9. https://pubmed.ncbi.nlm.nih.gov/36829181/
2. Li, H, Li, J, Su, Y, Tao, Q, Han, W. 2013. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. In Oncogene, 33, 3109-18. doi:10.1038/onc.2013.282. https://pubmed.ncbi.nlm.nih.gov/23893243/
3. Liu, Baocai, Lu, Yinliang, Zhang, Tingting, Jin, Shunzi, Cheng, Guanghui. 2021. CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity. In Cell communication and signaling : CCS, 19, 77. doi:10.1186/s12964-021-00720-3. https://pubmed.ncbi.nlm.nih.gov/34281589/
4. Jin, Yongdong, Qin, Xianpeng, Jia, Guiqing. 2018. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma. In Biochemical and biophysical research communications, 507, 91-99. doi:10.1016/j.bbrc.2018.10.172. https://pubmed.ncbi.nlm.nih.gov/30392914/
5. Huang, Zi-Ming, Li, Peng-Ling, Yang, Peng, Xu, Xin, Xu, Feng. 2019. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer. In The Kaohsiung journal of medical sciences, 35, 332-340. doi:10.1002/kjm2.12058. https://pubmed.ncbi.nlm.nih.gov/30903681/
6. Zhu, Zhipeng, Liu, Hanzhi, Fu, Huafeng, Zhang, Fuxing, Wang, Tao. 2024. CMTM7 shapes the chronic inflammatory and immunosuppressive tumor microenvironment in hepatocellular carcinoma as an M2 macrophage biomarker. In Scientific reports, 14, 29659. doi:10.1038/s41598-024-75538-3. https://pubmed.ncbi.nlm.nih.gov/39609464/
智鼠故事 
